2024-09-30T12:34:01-05:00 2023-12-31 871353108 EISNER ADVISORY GROUP LLC 733 THIRD AVENUE NEW YORK NY 100172703 990 2023-01-01 383110993 SEPSIS ALLIANCE INC SEPS 6192320300 3180 UNIVERSITY AVENUE STE 310 SAN DIEGO CA 92104 THOMAS N HEYMANN CHIEF EXECUTIVE OFFICER 6192320300 2024-09-28 1 0 WILLIAM EPSTEIN P01307171 2129498700 2023 2024-10-15 13:58:12Z X THOMAS N HEYMANN 3180 UNIVERSITY AVENUE SAN DIEGO CA 92104 3578104 0 X WWW.SEPSIS.ORG X 2007 MI TO SAVE LIVES AND REDUCE SUFFERING BY EDUCATING THE PUBLIC (CONTINUED ON SCHED O) (CONTINUED FROM PG 1, PART 1, LINE 1) AND LEADING AN ALLIANCE OF PATIENTS, HEALTHCARE PROFESSIONALS, AND PARTNERS COMMITTED TO PREVENTING AND CURING SEPSIS. 20 17 15 27 0 0 2380372 2180561 0 0 -33160 35371 13224 11173 2360436 2227105 0 0 0 0 1904521 2114553 0 0 319509 555870 619987 2460391 2734540 -99955 -507435 1766599 1504712 207848 469119 1558751 1035593 X TO SAVE LIVES AND REDUCE SUFFERING BY EDUCATING THE PUBLIC AND LEADING AN ALLIANCE OF PATIENTS, HEALTHCARE PROFESSIONALS, AND PARTNERS COMMITTED TO PREVENTING AND CURING SEPSIS. 0 0 528276 8366 PUBLIC AWARENESS, EDUCATION, & SUPPORT:SEPSIS ALLIANCE MAINTAINED THE SEPSIS.ORG WEBSITE SERVING MORE THAN 2 MILLION VISITORS WITH RELIABLE AND ACCURATE INFORMATION. PROGRAMMATIC WORK INCLUDED THE TRANSLATION OF SEVERAL ANTIMICROBIAL RESISTANCE AND INFECTION PREVENTION RELATED SEPSIS INFORMATION GUIDES TO SPANISH, TRADITIONAL CHINESE AND TAGALOG. ADDITIONAL PROGRAMMATIC WORK INCLUDED DEVELOPING INFECTION PREVENTION EDUCATION MATERIALS FOR PATIENTS RECEIVING AT HOME ANTI-INFECTIVE INFUSIONS IN ENGLISH AND SPANISH AND A COVID-19 EDUCATION PROGRAM TO REACH UNDER-VACCINATED AND UNDERSERVED COMMUNITIES. OTHER 2023 PROGRAMS INCLUDED A SEPSIS AND FLU EDUCATIONAL CAMPAIGN TO ADDRESS FLU PREVENTION, TREATMENT, AND MYTHS VS FACTS, AND THE DEVELOPMENT OF PATIENT EDUCATION (CONTINUED SCHEDULE O)(CONTINED FROM PART III, 4A) FOR CHILDREN AND ADULTS WITH INTELLECTUAL AND DEVELOPMENTAL DISABILITIES (IDD) INCLUDING A SEPSIS AND PAGE, A TEXT GUIDE, VISUAL GUIDE, AND COMPANION HEALTHCARE PROVIDER GUIDE. ADDITIONAL ACCOMPLISHMENTS INCLUDED CONDUCTING A PATIENT SURVEY TO BETTER UNDERSTAND THE PATIENT DIAGNOSTIC JOURNEY. MORE THAN 1,500 PATIENTS AND FAMILY MEMBERS PARTICIPATED IN THE SURVEY. SEPSIS ALLIANCE CELEBRATED THE ONE-YEAR ANNIVERSARY OF SEPSIS ALLIANCE CONNECT, A VIRTUAL SUPPORT COMMUNITY FOR SEPSIS SURVIVORS, CAREGIVERS, AND THOSE WHO HAVE LOST LOVED ONES AND LAUNCHED FIRST SEPSIS ALLIANCE CONNECT AFFINITY GROUP, WHICH WILL CREATE SPACE SPECIFICALLY FOR YOUNG ADULTS IN THE COMMUNITY. 763996 PROVIDER EDUCATION & TRAINING:SEPSIS ALLIANCE CONTINUED TO HOST LIVE AND ENDURING COURSES VIA SEPSIS ALLIANCE INSTITUTE UTILIZING A NEW PLATFORM WITH OVER 40,000 TOTAL LEARNERS TO DATE. OFFERINGS INCLUDED 245 TOTAL COURSES, OF WHICH 185 ARE COURSES WITH CNE (CONTINUED NURSING EDUCATION) CREDIT. SEPSIS ALLIANCE ALSO ADDED SEVEN CONTINUING EDUCATION WEBINARS INCLUDING A MATERNAL SEPSIS & EQUITY WEBINAR AND RECORDED OVER 4,300 RESOURCE LIBRARY DOCUMENTS DOWNLOADS IN 2023, WHICH WAS AN INCREASE OF 332% OVER THE PRIOR YEAR. THE ORGANIZATION HOSTED THE FOURTH ANNUAL SEPSIS ALLIANCE SUMMIT AND ANNUAL AMR (ANTIMICROBIAL RESISTANCE) CONFERENCES. 324284 ADVOCACY:SEPSIS ALLIANCE CONTINUED LEGISLATIVE EFFORTS TO CREATE A NATIONAL SEPSIS DATA TRUST AND A NATIONAL SEPSIS ACTION PLAN. ACTIVITIES INCLUDED MEETING WITH MORE THAN TWO DOZEN CONGRESSIONAL OFFICES IN SUPPORT OF THE PASSAGE OF LULU'S LAW AND SUBMITTING LULU'S LAW FUNDING REQUESTS TO CONGRESSIONAL OFFICES IN SUPPORT OF APPROPRIATIONS ($5 MILLION) FOR STATE SEPSIS DATA TRUSTS. SEPSIS ALLIANCE ALSO WORKED WITH ADVOCATES TO HAVE REQUESTS SUBMITTED TO APPROXIMATELY 100 CONGRESSIONAL OFFICES. OTHER ACTIVITIES INCLUDED PLANNING AND EXECUTING AN IN-PERSON LOBBYING EVENT/RECEPTION IN WASHINGTON, D.C. ON WORLD SEPSIS DAY, AND CONTINUED SUPPORT OF SEP-1 (THE SEVERE SEPSIS AND SEPTIC SHOCK MANAGEMENT BUNDLE), A KEY (CONTINUED SCHEDULE O)(CONTINED FROM PART III, 4C) CMS (CENTER FOR MEDICARE AND MEDICAID SERVICES) PROCESS MEASURE THAT DRIVES HOSPITAL FOCUS ON THE EARLY RECOGNITION, DIAGNOSIS AND TREATMENT OF SEPSIS. ADDITIONAL ENDEAVORS INVOLVED AN AMPLIFIED PATIENT ADVOCACY VOICE DURING NATIONAL QUALITY FORUM (NQF) MAP COORDINATING COMMITTEE REVIEW MUC MEETING, WHICH RESULTED IN THE SEP-1 MEASURE'S ENDORSEMENT STATUS BEING UPHELD. THIS WORK CULMINATED IN THE CMS (CENTER FOR MEDICARE AND MEDICAID SERVICES) ANNOUNCEMENT THAT SEP-1 WILL BE INCLUDED IN THE VBP (VALUE BASED PURCHASING) PROGRAM BEGINNING IN THE FY2026 PROGRAM YEAR.SEPSIS ALLIANCE REMAINED AN ACTIVE PARTICIPANT IN AMR (ANTIMICROBIAL RESISTANCE) COALITIONS, PROVIDING INFORMATION AND TALKING POINTS ON SEPSIS TO MEMBERS OF CONGRESS AHEAD OF AMR-RELATED HEARINGS TO ENCOURAGE DISCUSSION OF SEPSIS IN THE CONTEXT OF AMR. PARTICIPATION ALSO INCLUDED IN AN IN-PERSON AMR/PASTEUR ADVOCACY DAY, ORGANIZED BY IDSA (INFECTIOUS DISEASES SOCIETY OF AMERICA) AND OTHER LEADERS IN THE AMR SPACE, IN WASHINGTON D.C. ON SEPTEMBER 12, 2023.SEPSIS ALLIANCE CONTINUED TO FOCUS ON SEPSIS AWARENESS MONTH A SEPSIS ALLIANCE INITIATED OBSERVANCE THAT DRIVES ENGAGEMENT ON SEPSIS. ACCOMPLISHMENTS INCLUDED COMPLETION OF THREE ADVOCACY TRAINING WEBINARS THE APPROPRIATIONS PROCESS, SEPSIS AWARENESS MONTH ENGAGEMENT, AND SEPSIS AND ANTIMICROBIAL RESISTANCE. ADDITIONAL INVOLVEMENT INCLUDED WORK ALONGSIDE PARTNERS AT CDC TO CHAMPION ITS ROLLOUT OF THE SEPSIS CORE ELEMENTS PROGRAM WHICH OUTLINES STRUCTURAL AND PROCEDURAL COMPONENTS THAT ARE ASSOCIATED WITH THE MULTIDISCIPLINARY EXPERTISE REQUIRED TO SUPPORT THE CARE OF PATIENTS WITH SEPSIS. 440868 INNOVATION:SEPSIS ALLIANCE CONTINUED WORK ON THE IMSCC (INFECTION MANAGEMENT/SEPSIS COLLABORATIVE COMMUNITY) FUNDED THROUGH A COOPERATIVE AGREEMENT WITH ASPR (THE ADMINISTRATION FOR STRATEGIC PREPAREDNESS AND RESPONSE). ACCOMPLISHMENTS INCLUDED THE IMSCC OFFICIAL RECOGNITION BY FDA (U.S. FOOD AND DRUG ADMINISTRATION) AS ONE OF THEIR COLLABORATIVE COMMUNITIES WITH TWO FEDERAL LIAISONS AND CREATED TWO IMSCC VOLUNTEER MEMBER WORKGROUPS TO EXECUTE ASPR-FUNDED PROJECTS; RECRUITED OVER 40 VOLUNTEER SUBJECT MATTER EXPERTS AND C-SUITE LEVEL OFFICERS TO STAFF WORKGROUPS. ADDITIONAL EFFORTS IN 2023 INCLUDED WORK ON TWO PROJECTS: 1) UNDERSTANDING AND MEASURING THE PATIENT EXPERIENCE IN DIAGNOSING SEPSIS AND 2) DE-RISKING THE PRODUCT DESIGN AND REGULATORY PROCESS FOR INFECTION MANAGEMENT AND SEPSIS-RELATED DEVICES. SEPSIS ALLIANCE ESTABLISHED A MEMBER COMMUNITY WITHIN SIC (SEPSIS INNOVATION COLLABORATIVE) TO FOSTER COLLABORATION AND INNOVATION AMONG DIVERSE STAKEHOLDERS TO ADVANCE THE AVAILABILITY AND QUALITY OF DATA-DRIVEN SOLUTIONS TO IMPROVE SEPSIS OUTCOMES, ENHANCE PATIENT CARE, AND PROMOTE THE WELL-BEING OF SEPSIS SURVIVORS. ADDITIONALLY, SEPSIS ALLIANCE CONVENED A ROUNDTABLE TO ADVANCE THE RECOMMENDATIONS OF THE 2022 ROUNDTABLE ON SEPSIS DATA BY ESTABLISHING A STAKEHOLDER-LED PROCESS FOR ADDRESSING OPERATIONAL QUESTIONS CRITICAL TO A DATA TRUST; INITIATING A PROCESS TO DEVELOP AND PRIORITIZE USE CASES; AND HARMONIZING DATA VOCABULARIES AND DEFINITIONS BY EXPLORING A PARTNERSHIP WITH HEALTH LEVEL SEVEN INTERNATIONAL (HL7). 440868 2057424 1 1 0 1 0 0 0 0 0 0 1 0 0 1 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 27 0 15 1 0 0 0 0 0 0 0 0 0 0 X 20 17 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 1 1 1 1 0 CA FL IL KS MA MI MN NC NJ NY OH PA X X X THOMAS N HEYMANN 6192320300 3180 UNIVERSITY AVENUE SAN DIEGO CA 92104 X CINDY HOU CHIEF MEDICAL OFFICER 4.00 0.00 X 3750 0 0 KARIN MOLANDER DIRECTOR 5.00 0.00 X 500 0 0 STEVE SIMPSON BOARD CHAIR 15.00 0.00 X X 0 0 0 PAUL EPNER VICE CHAIR 15.00 0.00 X X 0 0 0 THERESA BROWN TREASURER 8.00 0.00 X X 0 0 0 JILL GRESS SECRETARY 15.00 0.00 X X 0 0 0 ERIN BORGER DIRECTOR 1.00 0.00 X 0 0 0 PAUL BURTON DIRECTOR 1.00 0.00 X 0 0 0 SANDY CAYO DIRECTOR 1.00 0.00 X 0 0 0 ERIKA COLLINS DIRECTOR 2.00 0.00 X 0 0 0 CARL FLATLEY DIRECTOR 10.00 0.00 X 0 0 0 KATY GRAINGER DIRECTOR 15.00 0.00 X 0 0 0 LUKAS HAYNES DIRECTOR 4.00 0.00 X 0 0 0 MIDORI LAWLER DIRECTOR 1.00 0.00 X 0 0 0 ANNE LYNCH DIRECTOR (THRU 3/9/2023) 0.00 0.00 X 0 0 0 CATRIONA MACDONALD DIRECTOR 5.00 0.00 X 0 0 0 HARI MENON DIRECTOR (THRU 5/3/2023) 1.00 0.00 X 0 0 0 WILLIAM MOONEY DIRECTOR 6.50 0.00 X 0 0 0 JIM O'BRIEN DIRECTOR 4.00 0.00 X 0 0 0 RANGARAJAN SAMPATH DIRECTOR 1.00 0.00 X 0 0 0 JENNIFER TAPPER DIRECTOR 1.00 0.00 X 0 0 0 MARK WEINSTEIN DIRECTOR 10.00 0.00 X 0 0 0 THOMAS HEYMANN CHIEF EXECUTIVE OFFICER 40.00 0.00 X 308898 0 12669 SAVANNAH STARK VP DEVELOPMENT & OPERATIONS 40.00 0.00 X 134400 0 0 SHION CHANG PROGRAM SUPERVISOR 40.00 0.00 X 114502 0 3887 562050 0 16556 3 0 1 0 0 407027 1773534 2180561 37253 37253 1346118 1348000 -1882 -1882 -1882 11365 2999 8366 8366 MISCELLANEOUS 900099 2807 2807 2807 2227105 8366 0 38178 327919 253509 40034 34376 1607600 1238639 200078 168883 28907 22579 3427 2901 150127 117265 17797 15065 43918 21959 21959 97453 97453 90000 90000 40831 7076 33755 56554 9821 46733 30967 16831 7706 6430 26905 21523 2691 2691 10100 6060 1010 3030 45015 32045 12470 500 1160 1160 27247 9860 12457 4930 DUES AND SUBSCRIPTIONS 119356 112804 3063 3489 FUNDRAISING FEES 30481 30481 2734540 2057424 357607 319509 712831 1293620 229333 72238 7256 7283 45486 39150 9566 9566 1160 0 768530 2003 92421 1766599 1504712 110161 246369 97687 222750 207848 469119 X 933368 605283 625383 430310 1558751 1035593 1766599 1504712 X -507435 3470 -19193 X 0 1 X 1 0 X 1012300 1713052 2231896 2380372 2180561 9518181 1012300 1713052 2231896 2380372 2180561 9518181 608445 8909736 158 4073 8124 37253 49608 2042 2673 1191 1600 2807 10313 9578102 201166 0.93020 0.92370 X SCHEDULE A, PART II, LINE 10, EXPLANATION OF OTHER INCOME: OTHER INCOME - 2019 AMOUNT: $ 2,042. 2020 AMOUNT: $ 2,673. 2021 AMOUNT: $ 1,191. 2022 AMOUNT: $ 1,600. 2023 AMOUNT: $ 2,807. RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 11729 110287 122016 1935408 2057424 252871 63218 0 0 242369 273020 287120 802509 1203764 6083 13810 110287 130180 60592 68255 71780 200627 300941 11729 11729 PART I-A, LINE 1: LOBBYING ACTIVITIES IS TO SERVE AS THE LEADING SEPSIS ADVOCACY ORGANIZATION AND TRUSTED EXPERT ON LEGISLATION AND PUBLIC POLICY THAT IMPROVES SEPSIS AWARENESS, EDUCATION, DIAGNOSIS, TREATMENT, AND SURVIVOR CARE. TO EDUCATE POLICYMAKERS, ADVOCATES, HEALTHCARE PROFESSIONALS, AND THE GENERAL PUBLIC ABOUT LEGISLATION, REGULATIONS, AND PUBLIC POLICIES THAT DIRECTLY IMPACT SEPSIS PATIENTS, SURVIVORS, AND LOVED ONES INCLUDING THE NEED FOR BETTER CONNECTED SEPSIS DATA ON THE STATE AND FEDERAL LEVELS; THE IMPACT OF ANTIMICROBIAL RESISTANCE ON SEPSIS AND THEIR RELATIONSHIP; AND SEPSIS MANAGEMENT AND TREATMENT GUIDANCE AS STIPULATED BY FEDERAL REGULATORY AND CARE REIMBURSEMENT ENTITIES. 9566 9566 0 0 SECURITY DEPOSITS 2003 RETAINERS 9618 CAPITALIZED IMPLEMENTATION COSTS, NET 80800 92421 X 2238001 3470 7426 10896 2227105 0 2227105 2761159 7426 19193 26619 2734540 0 2734540 PART X, LINE 2: THE ORGANIZATION IS SUBJECT TO THE PROVISIONS OF THE FINANCIAL ACCOUNTING STANDARDS BOARD'S (THE "FASB") ACCOUNTING STANDARDS CODIFICATION ("ASC") TOPIC 740, INCOME TAXES, AS IT RELATES TO ACCOUNTING AND REPORTING FOR UNCERTAINTY IN INCOME TAXES. FOR THE ORGANIZATION, THESE PROVISIONS COULD BE APPLICABLE TO THE INCURRENCE OF UNRELATED BUSINESS INCOME TAX ("UBIT") ON MERCHANDISE SALES. SINCE THE ORGANIZATION HAS ALWAYS RECORDED ANY POTENTIAL TAX AND DUE TO ITS GENERAL NOT-FOR-PROFIT STATUS, MANAGEMENT BELIEVES, ASC 740 HAS NOT HAD, AND IS NOT ANTICIPATED TO HAVE, A MATERIAL IMPACT ON THE ORGANIZATION'S FINANCIAL STATEMENTS. PART XII, LINE 2D - OTHER ADJUSTMENTS: BAD DEBT EXPENSE 19,193. X X X 0 0 0 0 0 0 0 1 0 THOMAS HEYMANN CHIEF EXECUTIVE OFFICER 234898 0 74000 0 0 0 0 0 12669 0 321567 0 0 0 PART I, LINE 7 EMPLOYEES ARE ELIGIBLE TO RECEIVE EACH CALENDAR YEAR A PERFORMANCE-BASED BONUS AS DETERMINED BY THE BOARD BASED ON THE ACHIEVEMENT OF ESTABLISHED GOALS OF THE ORGANIZATION. CATRIONA MACDONALD BOARD MEMBER 90000 LOBBYING 0 FORM 990, SCHEDULE L, PART IV, LINE 1 DURING 2023, SEPSIS ENGAGED LINCHPIN STRATEGIES LLC, OF WHICH BOARD MEMBER CATRIONA MACDONALD MAINTAINS AN OWNERSHIP INTEREST OF 35% OR MORE, TO CONDUCT LOBBYING ACTIVITIES FORM 990, PART VI, SECTION B, LINE 11B THE FINAL 990 IS REVIEWED AND APPROVED BY FINANCE COMMITTEE. THE 990 IS THEN SUBMITTED AFTER EVALUATING ALL COMMENTS BY THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION B, LINE 12C ANNUALLY EACH MEMBER OF THE BOARD OF DIRECTORS IS REQUIRED TO SUBMIT A SIGNED COPY OF THE CONFLICT OF INTEREST POLICY. FORM 990, PART VI, SECTION B, LINE 15 FORM 990, PART VI LINE 15A COMPENSATION PROCESS FOR TOP OFFICIAL COMPENSATION IS REVIEWED BY THE COMPENSATION COMMITTEE. COMMITTEE PREPARES RECOMMENDATIONS AND PROVIDES TO THE BOARD OF DIRECTORS. FORM 990, PART VI LINE 15B COMPENSATION PROCESS FOR OFFICERS COMPENSATION IS REVIEWED BY THE COMPENSATION COMMITTEE. COMMITTEE PREPARES RECOMMENDATIONS AND PROVIDES TO THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION C, LINE 19 DISCLOSURE OF GOVERNING DOCUMENTS, ETC. ARE PROVIDED UPON REQUEST AND APPROVAL OF THE BOARD OF DIRECTORS FOR THE SAME PERIOD OF DISCLOSURE AS SET FORTH UNDER IRC SECTION 6104(D). FORM 990, PART VII - COMPENSATION OF BOARD MEMBERS NO MEMBER OF THE BOARD OF DIRECTORS IS COMPENSATED FOR THEIR SERVICE TO THE ORGANIZATION AS A BOARD MEMBER. SOME BOARD MEMBERS PROVIDE SERVICES TO THE ORGANIZATION BASED ON THEIR SCIENTIFIC CREDENTIALS AS PART OF THE ORGANIZATION'S PROGRAM SERVICES. FORM 990, PART XI, LINE 9: BAD DEBT EXPENSE NOT REPORTED ON PART IX -19,193.